Transoral Microsurgery for Treatment of Laryngeal and Pharyngeal Cancers.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 134, doi. 10.1007/s11912-012-0286-0
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2013 AND VI 15 AND IP 2
Results: 17
1
2
Custirsen (OGX-011): Clusterin Inhibitor in Metastatic Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 113, doi. 10.1007/s11912-012-0285-1
- By:
- Publication type:
- Article
3
Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 152, doi. 10.1007/s11912-013-0297-5
- By:
- Publication type:
- Article
4
Anal Cancer: Are We Making Progress?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 170, doi. 10.1007/s11912-013-0296-6
- By:
- Publication type:
- Article
5
Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 146, doi. 10.1007/s11912-013-0298-4
- By:
- Publication type:
- Article
6
Perineural Invasion of Head and Neck Skin Cancer: Diagnostic and Therapeutic Implications.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 128, doi. 10.1007/s11912-012-0288-y
- By:
- Publication type:
- Article
7
Assessment of Treatment Response after Chemoradiation of Head and Neck Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 119, doi. 10.1007/s11912-012-0287-z
- By:
- Publication type:
- Article
8
Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 83, doi. 10.1007/s11912-013-0299-3
- By:
- Publication type:
- Article
9
Tasquinimod: A Novel Angiogenesis Inhibitor-Development in Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 65, doi. 10.1007/s11912-013-0295-7
- By:
- Publication type:
- Article
10
Cabozantinib as a Novel Therapy for Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 76, doi. 10.1007/s11912-012-0289-x
- By:
- Publication type:
- Article
11
Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 162, doi. 10.1007/s11912-012-0291-3
- By:
- Publication type:
- Article
12
Regorafenib (BAY 73-4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 91, doi. 10.1007/s11912-013-0292-x
- By:
- Publication type:
- Article
13
Efficacy of Neck Dissection in the Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 142, doi. 10.1007/s11912-013-0294-8
- By:
- Publication type:
- Article
14
Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 105, doi. 10.1007/s11912-013-0300-1
- By:
- Publication type:
- Article
15
Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 98, doi. 10.1007/s11912-012-0284-2
- By:
- Publication type:
- Article
16
The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 182, doi. 10.1007/s11912-012-0290-4
- By:
- Publication type:
- Article
17
Enzalutamide, a Second Generation Androgen Receptor Antagonist: Development and Clinical Applications in Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 69, doi. 10.1007/s11912-013-0293-9
- By:
- Publication type:
- Article